Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Crescita Therapeutics Inc (CRRTF)

Crescita Therapeutics Inc (CRRTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6821 +4.09%
on 12/18/19
0.7464 -4.88%
on 12/30/19
-0.0100 (-1.39%)
since 12/06/19
3-Month
0.6535 +8.65%
on 10/16/19
0.8005 -11.31%
on 10/28/19
+0.0310 (+4.57%)
since 10/11/19
52-Week
0.3400 +108.82%
on 03/20/19
0.9090 -21.89%
on 07/16/19
+0.3474 (+95.81%)
since 12/28/18

Most Recent Stories

More News
Crescita Reports 2019 Third Quarter Results

Revenue up 9.9% Year-over-Year Positive Adjusted EBITDA1 of $0.9 Million

CRRTF : 0.7100 (+3.44%)
CTX.TO : 0.90 (unch)
Crescita Reports 2019 Third Quarter Results

Revenue up 9.9% Year-over-Year Positive Adjusted EBITDA 1  of $0.9 Million

CRRTF : 0.7100 (+3.44%)
CTX.TO : 0.90 (unch)
U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita"), a commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription skincare products and prescription...

CRRTF : 0.7100 (+3.44%)
CTX.TO : 0.90 (unch)
U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®

LAVAL, QC , Nov. 5, 2019 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita"), a commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription...

CRRTF : 0.7100 (+3.44%)
CTX.TO : 0.90 (unch)
Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals

Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed producer of cannabis and Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) ("Crescita"), a Canadian commercial dermatology company,...

CRRTF : 0.7100 (+3.44%)
SNDL : 3.46 (+5.81%)
CTX.TO : 0.90 (unch)
Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals

CALGARY and LAVAL, QC, Oct. 28, 2019 /PRNewswire/ - Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed producer of cannabis and Crescita Therapeutics Inc. (TSX: CTX and OTC US:...

SNDL : 3.46 (+5.81%)
CRRTF : 0.7100 (+3.44%)
CTX.TO : 0.90 (unch)
Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals

CALGARY and LAVAL, QC , Oct. 28,  2019 /PRNewswire/ - Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed producer of cannabis and Crescita Therapeutics Inc. (TSX: CTX) and (OTC...

CRRTF : 0.7100 (+3.44%)
CTX.TO : 0.90 (unch)
SNDL : 3.46 (+5.81%)
Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

NEW YORK, NY / ACCESSWIRE / September 5, 2019 / Crescita Therapeutics Inc. (TSX:CTX)(OTC Pink:CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities...

CRRTF : 0.7100 (+3.44%)
CTX.TO : 0.90 (unch)
Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

LAVAL, QC , Sept. 5, 2019 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities...

CRRTF : 0.7100 (+3.44%)
CTX.TO : 0.90 (unch)
Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription skincare...

CRRTF : 0.7100 (+3.44%)
CTX.TO : 0.90 (unch)
Trade CRRTF with:

Key Turning Points

2nd Resistance Point 0.7167
1st Resistance Point 0.7133
Last Price 0.7100
1st Support Level 0.7083
2nd Support Level 0.7067

See More

52-Week High 0.9090
Last Price 0.7100
Fibonacci 61.8% 0.6916
Fibonacci 50% 0.6245
Fibonacci 38.2% 0.5574
52-Week Low 0.3400

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar